To be honest they were right the first time. They raised concerns of Paxlovid Revenue being one off, which was later acknowledged by management. I believe these recent posts in this topic including mine doesn’t add value to the thread. So, I’ll soon delete this post and ask others to consider the same
| Subscribe To Our Free Newsletter |
